tadalafil has been researched along with Cryopyrin-Associated Periodic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, M; Imai, S; Kitada, N; Koyanagi, M; Matsubara, K; Nakagawa, S; Nakagawa, T; Ogihara, T; Omura, T; Yonezawa, A | 1 |
1 other study(ies) available for tadalafil and Cryopyrin-Associated Periodic Syndromes
| Article | Year |
|---|---|
Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice.
Topics: Animals; Behavior, Animal; Cryopyrin-Associated Periodic Syndromes; Ganglia, Spinal; Humans; Mice; Mice, Inbred C57BL; Oxaliplatin; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; Sciatic Nerve; Skin; Tadalafil; Vascular System Injuries; Vasodilator Agents | 2019 |